Showing results (1-10 of 8) with videos related to
Sort By:
Pageof 1
Pharmacogenomics|June 9, 2016
Pharmacogenetics of anthracyclinesJudit C Sági, Nóra Kutszegi, Andrea Kelemen, et al.Haematologica|June 10, 2017
HLA-DRB1*07:01-HLA-DQA1*02:01-HLA-DQB1*02:02 haplotype is associated with a high risk of asparaginase hypersensitivity in acute lymphoblastic leukemiaNóra Kutszegi, Xiaoqing Yang, András Gézsi, et al.Plos One|October 13, 2015
Subgroups of Paediatric Acute Lymphoblastic Leukaemia Might Differ Significantly in Genetic Predisposition to Asparaginase HypersensitivityNóra Kutszegi, Ágnes F Semsei, András Gézsi, et al.Journal of Translational Medicine|November 16, 2019
Circulating microRNAs as minimal residual disease biomarkers in childhood acute lymphoblastic leukemiaAndrea Rzepiel, Nóra Kutszegi, András Gézsi, et al.Molecular and Cellular Probes|January 14, 2023
MiR-128-3p as blood based liquid biopsy biomarker in childhood acute lymphoblastic leukemiaAndrea Rzepiel, Anna Horváth, Nóra Kutszegi, et al.Journal of Translational Medicine|June 24, 2020
MicroRNA-181a as novel liquid biopsy marker of central nervous system involvement in pediatric acute lymphoblastic leukemiaBálint Egyed, Nóra Kutszegi, Judit C Sági, et al.BMC Cancer|July 5, 2018
Possible roles of genetic variations in chemotherapy related cardiotoxicity in pediatric acute lymphoblastic leukemia and osteosarcomaJudit C Sági, Bálint Egyed, Andrea Kelemen, et al.Cancers|June 2, 2021
Pharmacogenetics of the Central Nervous System-Toxicity and Relapse Affecting the CNS in Pediatric Acute Lymphoblastic LeukemiaJudit C Sági, András Gézsi, Bálint Egyed, et al.Pageof 1